Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial

Madhi, Shabir A, Cutland, Clare L, Jose, Lisa, Koen, Anthonet, Govender, Niresha, Wittke, Frederick, Olugbosi, Morounfolu, Meulen, Ajoke Sobanjo-ter, Baker, Sherryl, Dull, Peter M, Narasimhan, Vas, Slobod, Karen·2016·The Lancet Infectious Diseases

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(16)00152-3

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 33

  1. Shah, 2014, Neonatal sepsis: an old problem with new insights, Virulence, 5, 170, 10.4161/viru.26906 · DOI · Paper page
  2. Verani, 2010, Group B streptococcal disease in infants: progress in prevention and continued challenges, Clin Perinatol, 37, 375, 10.1016/j.clp.2010.02.002 · DOI
  3. Cutland, 2009, Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial, Lancet, 374, 1909, 10.1016/S0140-6736(09)61339-8 · DOI
  4. Thigpen, 2011, Bacterial meningitis in the United States, 1998–2007, N Engl J Med, 364, 2016, 10.1056/NEJMoa1005384 · DOI · Paper page
  5. Jordan, 2008, Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease a multistate, population-based analysis, Pediatr Infect Dis J, 27, 1057, 10.1097/INF.0b013e318180b3b9 · DOI · Paper page
  6. Simister, 2003, Placental transport of immunoglobulin G, Vaccine, 21, 3365, 10.1016/S0264-410X(03)00334-7 · DOI · Paper page
  7. Englund, 2007, The influence of maternal immunization on infant immune responses, J Comp Pathol, 137, S16, 10.1016/j.jcpa.2007.04.006 · DOI · Paper page
  8. Baker, 1976, Correlation of maternal antibody deficiency with susceptibility to neonatal Group-B Streptococcal infection, N Engl J Med, 294, 753, 10.1056/NEJM197604012941404 · DOI · Paper page
  9. Lin, 2001, Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: a multicenter, seroepidemiology study, J Infect Dis, 184, 1022, 10.1086/323350 · DOI
  10. Lin, 2004, Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen, J Infect Dis, 190, 928, 10.1086/422756 · DOI
  11. 2012, Vaccines against influenza WHO position paper—November 2012, Wkly Epidemiol Rec, 87, 461
  12. Dangor, 2015, Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants, PLoS One, 10, e0123014, 10.1371/journal.pone.0123014 · DOI
  13. Edmond, 2012, Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis, Lancet, 379, 547, 10.1016/S0140-6736(11)61651-6 · DOI · Paper page
  14. Madhi, 2013, Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants, Vaccine, 31, D52, 10.1016/j.vaccine.2013.02.029 · DOI
  15. Madhi, 2003, High burden of invasive Streptococcus agalactiae disease in South African infants, Ann Trop Paediatr, 23, 15, 10.1179/000349803125002814 · DOI
  16. Leroux-Roels, 2016, A randomized, observer-blind phase Ib study to identify formulations and vaccine schedules of a trivalent group B streptococcus vaccine for use in non-pregnant and pregnant women, Vaccine, 34, 1786, 10.1016/j.vaccine.2016.02.044 · DOI
  17. Donders, 2016, Maternal immunisation with a trivalent glycoconjugate GBS vaccine—a phase II randomised study, Obstet Gynecol, 127, 213, 10.1097/AOG.0000000000001190 · DOI
  18. Afshar, 2011, International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci), J Clin Microbiol, 49, 1475, 10.1128/JCM.02365-10 · DOI
  19. Blencowe, 2012, National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications, Lancet, 379, 2162, 10.1016/S0140-6736(12)60820-4 · DOI · Paper page
  20. Palmeira, 2012, IgG placental transfer in healthy and pathological pregnancies, Clin Dev Immunol, 2012, 985646, 10.1155/2012/985646 · DOI · Paper page
  21. Baker, 2003, Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine, Vaccine, 21, 3468, 10.1016/S0264-410X(03)00353-0 · DOI · Paper page
  22. Heyderman, 2016, Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial, Lancet Infect Dis, 10.1016/S1473-3099(15)00484-3 · DOI
  23. Andrews, 2014, Serotype-specific effectiveness and correlates of prtoection for the 13-valent pneucoccal conjugate vaccine: a post-licensure indirect cohort study, Lancet Infect Dis, 19, 839, 10.1016/S1473-3099(14)70822-9 · DOI · Paper page
  24. McIntosh, 2015, Serum bactericidal antibody assays–The role of complement in infection and immunity, Vaccine, 33, 4414, 10.1016/j.vaccine.2015.07.019 · DOI
  25. Badri, 1977, Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women, J Infect Dis, 135, 308, 10.1093/infdis/135.2.308 · doi:10.1093/infdis/135.2.308
  26. Botta, 1979, Hormonal and type-dependent adhesion of group B streptococci to human vaginal cells, Infect Immun, 25, 1084, 10.1128/iai.25.3.1084-1086.1979 · doi:10.1128/iai.25.3.1084-1086.1979
  27. Hansen, 2004, Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants, J Clin Microbiol, 42, 83, 10.1128/JCM.42.1.83-89.2004 · DOI
  28. Kwatra, 2015, Natural acquired humoral immunity against serotype-specific group B streptococcus rectovaginal colonization acquisition in pregnant women, Clin Microbiol Infect, 21, 568e13, 10.1016/j.cmi.2015.01.030 · DOI
  29. Kwatra G, Adrian PV, Shiri T, Cutland CL, Madhi SA. Serotype specific cellular mediated immunity associated with clearance of homotypic group B streptococcus recto-vaginal colonization in pregnant women. J Infect Dis (in press).
  30. Dangor, 2014, Review on the association of group B streptococcus capsular antibody and protection against invasive disease in infants, Expert Rev Vaccines, 22, 1
  31. Baker, 2014, Maternal antibody at delivery protects neonates from early onset group B streptococcal disease, J Infect Dis, 209, 781, 10.1093/infdis/jit549 · DOI
  32. Cutland, 2015, Increased risk for group B streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004–2008, Emerg Infect Dis, 21, 638, 10.3201/eid2104.141562 · DOI
  33. Cutland, 2015, Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country, Vaccine, 33, 6406, 10.1016/j.vaccine.2015.08.040 · DOI

Cited by

See all 165

Metadata

Authors
Madhi, S. A., Cutland, C. L., Jose, L., Koen, A., Govender, N., Wittke, F., Olugbosi, M., Meulen, A. S.-T., Baker, S., Dull, P. M., Narasimhan, V., & Slobod, K.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2016-08
Volume
16
Issue
8
Pages
923-934
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2342773131
Cited by
165
References
1
FWCI
25.09
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. https://app.cochat.ai/papers/10.1016/s1473-3099(16)00152-3
The paper
Madhi, S. A., Cutland, C. L., Jose, L., Koen, A., Govender, N., Wittke, F., Olugbosi, M., Meulen, A. S.-T., Baker, S., Dull, P. M., Narasimhan, V., & Slobod, K. (2016). Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(16)00152-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.